MODIFIED, HYDROXY-SUBSTITUTED AROMATIC STRUCTURES HAVING CYTOPROTECTIVE ACTIVITY
申请人:Covey F. Douglas
公开号:US20060009438A2
公开(公告)日:2006-01-12
Abstract of the Disclosure
The present invention is directed to a process for conferring cytoprotection on a population of cells which comprises administering to that population of cells a compound comprising a hydroxy-substituted aromatic ring structure and a non-fused polycyclic, hydrophobic substituent attached thereto. In particular, the present invention is directed to such a process wherein the administered compound is phenolic, such as a steriod (e.g., estrogen), and has a non-fused polycyclic, hydrophobic substituent attached to the hydroxy-substituted A-ring thereof.
Tert-butyl-substituted aromatic steroids having cytoprotective activity
申请人:Washington University
公开号:EP1834959A2
公开(公告)日:2007-09-19
The present invention is directed to modified, hydroxy-bearing aromatic ring structures having cytoprotective activity. More specifically, in a first embodiment the present invention is directed to phenolic compounds, and in particular steriods (eg., estrogens), hydrophobic substituent is attached to the hydroxy-substituted A-ring thereof. The present invention is further directed to a process for conferring cytoprotection to a population of cells involving the administration of the compound.
本发明涉及具有细胞保护活性的经修饰的含羟基芳环结构。更具体地说,在第一个实施方案中,本发明涉及酚类化合物,特别是类固醇(如雌激素),疏水取代基连接到其羟基取代的 A 环上。本发明还进一步涉及一种对细胞群赋予细胞保护作用的工艺,该工艺涉及给药该化合物。
US6844456B2
申请人:——
公开号:US6844456B2
公开(公告)日:2005-01-18
US9156876B2
申请人:——
公开号:US9156876B2
公开(公告)日:2015-10-13
[EN] MODIFIED, HYDROXY-SUBSTITUTED AROMATIC STRUCTURES HAVING CYTOPROTECTIVE ACTIVITY<br/>[FR] STRUCTURES DE CYCLES AROMATIQUES MODIFIES A SUBSTITUTION HYDROXY ET A ACTIVITE CYTOPROTECTRICE
申请人:UNIV WASHINGTON
公开号:WO2002036605A2
公开(公告)日:2002-05-10
The present invention is directed to modified, hydroxy-bearing aromatic ring structures having cytoprotective activity. More specifically, in a first embodiment the present invention is directed to phenolic compounds, and in particular steroids (e.g., estrogens), wherein a non-fused polycyclic, hydrophobic substituent is attached to the hydroxy-substituted A-ring thereof. The present invention is further directed to a process for conferring cytoprotection to a population of cells involving the administration of the compounds.